Homburger and Davis Polk advised SOPHiA GENETICS on the deal. Lenz & Staehelin acted as Swiss counsel to the underwriters. SOPHiA GENETICS SA listed its shares...
SOPHiA GENETICS’ $234 Million Initial Public Offering on Nasdaq
ArchiMed’s Acquisition of Stragen Pharma Group
Walder Wyss advised Stragen Pharma and its shareholders in the transaction. Homburger acted as Swiss legal counsel to ArchiMed. Private equity healthcare fund ArchiMed announced the...